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ABSTRACT The susceptibility of the Iberian ibex (Capra pyrenaica) to Mycoplasma
conjunctivae ocular infection and the changes in their interaction over time were
studied in terms of clinical outcome, molecular detection, and IgG immune response
in a captive population that underwent a severe infectious keratoconjunctivitis (IKC)
outbreak. Mycoplasma conjunctivae was detected in the Iberian ibex, coinciding with
the IKC outbreak. Its prevalence had a decreasing trend in 2013 that was consistent
with the clinical resolution (August, 35.4%; September, 8.7%; November, 4.3%). Infec-
tions without clinical outcome were, however, still detected in the last handling in
November. Sequencing and cluster analyses of the M. conjunctivae strains found 1
year later in the ibex population conﬁrmed the persistence of the same strain lin-
eage that caused the IKC outbreak but with a high prevalence (75.3%) of mostly
asymptomatic infections and with lower DNA load of M. conjunctivae in the eyes
(mean quantitative PCR [qPCR] cycle threshold [CT], 36.1 versus 20.3 in severe IKC).
Signiﬁcant age-related differences of M. conjunctivae prevalence were observed only
under IKC epizootic conditions. No substantial effect of systemic IgG on M. conjunctivae
DNA in the eye was evidenced with a linear mixed-models selection, which indicated
that systemic IgG does not necessarily drive the resolution of M. conjunctivae infection
and does not explain the epidemiological changes observed. The results show how
both epidemiological scenarios, i.e., severe IKC outbreak and mostly asymptom-
atic infections, can consecutively occur by entailing mycoplasma persistence.
IMPORTANCE Mycoplasma infections are reported in a wide range of epidemiologi-
cal scenarios that involve severe disease to asymptomatic infections. This study al-
lows a better understanding of the transition between two different Mycoplasma
conjunctivae epidemiological scenarios described in wild host populations and high-
lights the ability of M. conjunctivae to adapt, persist, and establish diverse interactions
with its hosts. The proportion of asymptomatic and clinical M. conjunctivae infections in
a host population may not be regarded only in response to intrinsic host species traits
(i.e., susceptibility) but also to a speciﬁc host-pathogen interaction, which in turn inﬂu-
ences the infection dynamics. Both epidemic infectious keratoconjunctivitis and a high
prevalence of asymptomatic M. conjunctivae infections may occur in the same host pop-
ulation, depending on the circulation of M. conjunctivae, its maintenance, and the pro-
gression of the host-pathogen interactions.
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Mycoplasma spp. are small bacteria without a cell wall that have a strict parasitic lifein association with their hosts, either as commensals or pathogens (1). Myco-
plasma has several singular mechanisms for host adaptation and survival (2–4), which
includes one of the highest nucleotide substitution rates among bacteria that provides
chances for novel interactions with its hosts (5, 6). Mycoplasma infections can therefore
involve diverse epidemiological scenarios, resulting either in the development of severe
disease or in asymptomatic carriers that may or maybe not further develop clinical
symptoms (1, 7). To properly assess host-mycoplasma interaction dynamics, a longitu-
dinal sampling design is required. Unfortunately, such sampling conditions are usually
unfeasible in wild host species.
Infectious keratoconjunctivitis (IKC) is a contagious ocular disease caused by Myco-
plasma conjunctivae that affects small domestic ruminants and, more importantly, wild
Caprinae, in which mortality can reach 30% (8). Despite being a long-known disease of
wild mountain ungulates (9), several aspects of IKC epidemiology in natural systems are
not fully understood, and apparent differences in susceptibility are associated with host
species and its functional roles in alpine multihost systems (10–13). Clinical stages of
IKC may evolve from conjunctivitis to several degrees of keratoconjunctivitis, with
clinical recovery as the predominant outcome of the disease (14, 15). Mycoplasma
conjunctivae may still persist in the eyes up to 6 months beyond the disappearance of
clinical signs (14, 15).
Whereas endemic and subclinical infections of M. conjunctivae are common among
small domestic ruminants, mainly in sheep (16), subclinical infections in wild mountain
ungulates are reported less often and/or occur at a lower prevalence (11, 12). The local
fading out of clinical disease (IKC) and the more severe clinical signs typically exhibited
by wild hosts have led some to propose that M. conjunctivae cannot be maintained in
wild host populations (10, 17–19). However, diverse epidemiological scenarios have
been described in wild Caprinae based on ﬁeld records of IKC, including its apparently
endemic occurrence (12, 20). The recurrent detection of M. conjunctivae strain clusters
in wild host populations also suggests that it may eventually persist in natural systems
(20).
Mycoplasma conjunctivae infection elicits a strong immune IgG response, as de-
scribed for IKC outbreaks in wild Caprinae (21), and may be an important component
of the host immune response. Nevertheless, ﬁeld observations suggest that acquired
immunity does not prevent subsequent IKC episodes (8). Therefore, the maintenance of
speciﬁc IgG may be crucial to avoid M. conjunctivae persistence in the host population.
Susceptibility of the Iberian ibex (Capra pyrenaica) to M. conjunctivae infection has
been reported to be associated with a few sporadic IKC cases in massifs from Spain but,
to our knowledge, no IKC outbreaks have been described (22, 23). This medium-size
Caprinae is a species endemic to the Iberian Peninsula and is adapted to rocky
mountain ecosystems. It inhabits the Mediterranean mountain ranges of the Iberian
Peninsula, where it is the most abundant mountain ungulate, with over 50,000 ibexes
(24).
In this study, an IKC outbreak in the Iberian ibex is described, taking advantage of
the opportunity to perform individual sequential sampling in a captive population of 60
individuals. The objectives of this study were to (i) assess Iberian ibex susceptibility to
M. conjunctivae infection in captive and free-ranging animals and describe the dynam-
ics of the IKC outbreak, (ii) assess the presence of M. conjunctivae in the ibex population
1 year later, (iii) evaluate the inﬂuences of sex and age on M. conjunctivae infection, and
(iv) investigate the relationships between clinical signs, molecular detection, and IgG
immune response against M. conjunctivae and possible changes over time.
RESULTS
Clinical follow-up and course of the IKC outbreak. Ocular clinical signs were not
observed in ibexes sampled in 2010 and 2011. The ﬁrst evidence of ocular disease
appeared on 1 July 2013, when two Iberian ibexes with severe ocular clinical signs were
captured by hand due to visual impairment and total blindness. Both ibexes suffered
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from bilateral keratoconjunctivitis with widespread corneal opacity and abundant
neovascularization in the peripheral cornea, accompanied by severe mucopurulent
effusion, corresponding to IKC stage III (Fig. 1). From the ﬁrst handling in August 2013
to November 2013, the ocular clinical signs progressed from predominantly severe
clinical signs (IKC stages II and III) to chronic and healing stages V and VI (Fig. 1 and 2A).
Clinical signs were bilateral mainly in severe IKC stages II (1/2) and III (7/9) and less
common in initial IKC stage I (0/1) and healing stages V (2/14) and VI (3/9). Bilateral
infections were different between eyes only in two cases, with one showing IKC stages
V and VI and the other one showing IKC stages II and III. Among age categories,
younger ibexes and especially kids had a higher proportion of severe clinical signs (IKC
stages II and III) than older animals (Fig. 3). No IKC stage IV (severe IKC signs) or direct
mortality was attributable to M. conjunctivae infection during the IKC outbreak. Only
one ibex showed unilateral IKC stage V in November 2014. Although ocular clinical
signs were observed in free-ranging ibexes from the Sierra Nevada Natural Space
(SNNS) in 2013, they were not present in any of the 17 ibexes captured and sampled
outside the enclosure.
Mycoplasma conjunctivae qPCR detection and sequencing. Mycoplasma conjunc-
tivae was ﬁrst detected in ibexes showing IKC in July 2013. The prevalence showed
a decreasing trend from August 2013 until November 2013, in concordance with
the course of the clinical signs (Table 1 and Fig. 2A and B). Two ibexes that were
quantitative PCR (qPCR) positive for M. conjunctivae and/or showed IKC in August 2013
were qPCR negative by September 2013, and they turned qPCR positive in November
2013 (Fig. 4, ibexes 501 and ALP-276). The prevalence of M. conjunctivae rose again in
November 2014 to signiﬁcantly higher values than those of all 2013 handlings (August,
2  17.1, df  1, P  0.001; September, 2  46.5, df  1, P  0.001; November, 2 
53.1, df  1, P  0.001), in the absence of clinical signs in most of the ibexes (Table 1
FIG 1 Ocular lesions in Iberian ibex corresponding to IKC stages of disease severity and resolution observed during the natural course of
an IKC outbreak. (A) Normal eye appearance of Iberian Ibex. (B) IKC stage II with moderate corneal opacity, neovascularization of the
peripheral cornea, and ocular discharge. (C) IKC stage III with severe corneal opacity, neovascularization of the peripheral cornea, and
ocular discharge. (D) Chronic IKC stage III with infraorbital alopecia. (E to G) Different IKC stage V corresponding to healing process with
neovascularization of the vertex of the cornea, slight central corneal opacity, and evidences of a central ulcer in F and G. (H) IKC stage
VI, pigmentation of the cornea.
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and Fig. 2B). One out of the 17 free-ranging Iberian ibexes sampled was positive for M.
conjunctivae by the qPCR (Table 1).
Asymptomatic infections were detected in 11 out of 17 (64.7%) qPCR-positive ibexes
in August 2013, 0 out of four ibexes (0.0%) in September 2013, and one out of two
ibexes (50.0%) in November 2013. Fifty-one out of the 52 (98.1%) qPCR-positive ibexes
in November 2014 were asymptomatic, as was the free-ranging positive ibex. With
regard to the whole population, asymptomatic infections were higher in August 2013
(22.9%) during the IKC outbreak and in November 2014 (73.9%) than in September
2013 (0.0%) and November 2013 (2.2%).
Among the M. conjunctivae-infected ibexes, qPCR-positive eyes were 100% bilateral
in July 2013 (2/2), 47.1% in August 2013 (8/17), 50.0% in September 2013 (2/4), 0% in
November 2013 (0/2), and 46.1% in November 2014 (24/52). Infection of both eyes was
associated with severe IKC signs (stages II and III) in 2013 (10 out of 12 bilateral
infections) but not in 2014, when no ibexes showed severe IKC signs.
Only two ibex kids with severe IKC were qPCR positive in two consecutive samplings
in 2013, which implies that were probably infected for at least 7 weeks. The prevalence
of M. conjunctivae was inversely related to age class during the outbreak of IKC in 2013
(2  19.24, df  4, P  0.001) but not in 2014 (2  7.73, df  4, P  0.102) (Fig. 3).
The detection of M. conjunctivae by qPCR was consistent in IKC stages with evidence
of current inﬂammation (IKC stage I, 1/1; IKC stage II, 1/2; and IKC stage III, 8/9), but not
in healing IKC stage V (4/14) or with evidences of past inﬂammatory processes in IKC
FIG 2 Clinical, serological, and molecular trends of M. conjunctivae infection in the Iberian ibex population. Results showed handlings that
correspond with two epidemiological scenarios, epizootic IKC disease in 2013 and mostly asymptomatic infections in 2014. (A) Number of IKC
cases by clinical stage. (B) Prevalence of M. conjunctivae-seropositive ibexes assessed by an indirect ELISA and prevalence of M. conjunctivae
detection in eye swabs by qPCR. Ninety-ﬁve percent conﬁdence intervals are represented by error bars. (C) Distribution of CT values of the M.
conjunctivae-speciﬁc qPCR. Note that box plot of CT values from November 2013 is built with only two observations. (D) Absorbance relative values
of the indirect ELISA that recognize IgG speciﬁc for M. conjunctivae.
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stage VI (0/9). The mean threshold cycle (CT) values of the qPCR were signiﬁcantly lower
in the severe IKC stages II and III (20.3) than in IKC resolution stage V (mean CT, 35.1; P
0.045) and asymptomatic ibexes (mean CT, 36.1; P  0.001). The only IKC stage I
observed had a high CT value (38.3; see Fig. 5). The mean CT values of the qPCR-positive
samples increased progressively in the consecutive handlings from September 2013
onwards, in accordance with the fading away of the clinical signs throughout the
outbreak of 2013 and 2014 (Fig. 2C).
Eighteen PCR amplicons of approximately 700 bp that corresponded to the variable
domain of the M. conjunctivae lppS gene were sequenced from nine ibexes sampled in
2013 (two ibexes from July, C_507 and C_686; ﬁve ibexes from August, C_506, C_508,
C_800, C_801, and C_695; and two ibexes from September, C_2298 and C_5125) and
four ibexes sampled in November 2014 (C_501, C_801, 575N, and ALP321). The M.
conjunctivae strains causing the IKC outbreak in 2013 and those associated with
asymptomatic infections from 2014 belonged to the same cluster, which was clearly
separated from the rest of the sequences included in the tree, suggesting a phyloge-
netic relationship and a common origin (Fig. 6).
ELISA for M. conjunctivae antibodies. The cutoff determined by the Youden index
resulted in a sensitivity of 93.9% and a speciﬁcity of 84.3% for the enzyme-linked
immunosorbent assay (ELISA). The seroprevalence was higher in the ﬁrst handling
FIG 3 (A to C) Mycoplasma conjunctivae infection cases (A), clinical signs (KC) (B), and prevalence (C) shown by age class
(K, kids; Y, yearlings; Yg, young; P, prime age; S, senescence) in the Iberian ibex population in two different epidemiological
scenarios, an IKC outbreak in 2013 and mostly asymptomatic infections in 2014. Higher M. conjunctivae prevalence and
more severe clinical signs are observed in kids only during the IKC outbreak.
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(August 2013) and decreased steadily across all the consecutive samplings (Table 1 and
Fig. 2B). Among ibexes that were negative to the ELISA in August 2013, 33% (4/12)
turned positive in September 2013. Among ibexes that were negative to the ELISA in
September 2013, 33% (4/12) turned positive in November 2013. Both the mean and
individual ELISA values showed a similar decreasing trend throughout the 2013 and
2014 handlings (Fig. 2D and 4).
The number of qPCR-positive ibexes that also had a positive result to the ELISA
decreased across sampling periods. In August 2013 82.4% (14/17) of the qPCR-positive
ibexes showed evidence of a systemic IgG response. In September, however, this
proportion decreased to 25% (1/4), slightly rising in November 2013 (50% [1/2]) and
2014 (61.9% [9/21]). The ELISA value of each individual declined steadily after the ﬁrst
M. conjunctivae detection in the eye swabs in most of the ibexes (Fig. 4). The ELISA
FIG 4 Bar graph showing individual trends of the ELISA results from a random selection of ibexes that were sampled in most of the handlings in 2013 during
the IKC outbreak and in 2014 with mostly asymptomatic infections. Numbers on the x axis are the individual ibex reference, and the ELISA results on the y axis
correspond to the relative percentage from the positive reference standard. The detection of M. conjunctivae in eye swabs is shown with a red asterisk in the
top of the bars, and the cutoff for seropositivity is shown with a horizontal dashed line. The asterisk in parentheses above the bar for ibex 507 indicates that
it corresponds to a previous sampling in July 2013.
FIG 5 Violin plot showing the distribution of the CT values in eye swabs in IKC clinical stages that were
qPCR positive. CT values were signiﬁcantly lower in severe IKC stages (II and III) than initial (I) and healing
stages (V) and asymptomatic infections (0). Black bars show the interquartile range, and black dots
indicate the median of the CT values for each group.
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values were not clearly related to the presence or the severity of the clinical signs, and
three ibexes with severe IKC did not seroconvert during or after the M. conjunctivae
infection (e.g., Fig. 4, ibex 506).
None of the selected linear mixed models included the optical density of the ELISA
as an explanatory ﬁxed effect (Table 2), which indicated that no substantial variability
of the CT values was explained by the ELISA results (proxy for IgG). The best model
included only the age of the ibexes, which explained 68.35% of the observed variability
of CT values (Akaike weight by age [wiage]  0.80, F  17.36). A small proportion of the
CT response was due to the ibex random term (17.05%) (Table 2).
DISCUSSION
Iberian ibex susceptibility to M. conjunctivae infection has been clearly conﬁrmed by
this study, which can suffer from IKC outbreaks but also can maintain M. conjunctivae
FIG 6 Cluster analysis of the M. conjunctivae strains detected in this study based on the variable domain
of the lppS gene. Name of sequence indicates the individual reference followed by right (OD) or left (OI) eye
from which M. conjunctivae was detected. The year of sampling is shown with a black or white dot for 2013
or 2014, respectively. For comparison, sequences from isolates in other hosts are included: HRC/581 type
strain, sequences obtained in sheep infections in eastern Swiss Alps (38 s and 2820 s) and Croatia (My 66
95), from a goat in Croatia (My 7/96), and from chamois in the Austrian Alps (2778 c and 2784 c). A separate
clade of the ibex strains, all with a common origin, is observed in the tree.
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at high prevalence with mostly asymptomatic infections. Both epidemiological situa-
tions (i.e., IKC outbreak and endemic asymptomatic infections) have been described in
other domestic (16, 25) and wild free-ranging (12, 20, 26, 27) hosts. The results of the
present study show how both epidemiological situations can occur consecutively in a
host population, depending on M. conjunctivae circulation, its maintenance in the
population, and the progression of the host-pathogen interactions.
Infectious keratoconjunctivitis outbreak. There are few reports of IKC in Iberian
ibex, and we are not aware of any prior descriptions of an IKC outbreak. The consistent
detection of M. conjunctivae in severe IKC stages (II and III) and the correlation of CT
values with IKC stages conﬁrm that it was the primary agent of the outbreak. Ibexes
that showed IKC stages II and III in which M. conjunctivae was not detected were
seropositive and most probably correspond to false-negative results of the detection
method (sampling/qPCR), or, less probably, were caused by other infectious agents (28,
29). The absence of M. conjunctivae in advanced and healing IKC stages V and VI agrees
with resolution of the infection and with previous research (30). Since M. conjunctivae
was not detected in the captive ibex population before 2013 and was also conﬁrmed
in free-ranging ibexes from the surrounding SNNS (clinical signs compatible with IKC
were also observed; data not shown), M. conjunctivae was probably introduced along
with asymptomatic carriers or was transported by eye-frequenting insects from outside
the enclosure (31). Previous research in the Iberian ibex population from SNNS failed to
detect M. conjunctivae (32), which suggests a likely recent introduction of this Myco-
plasma in the SNNS ibex population.
Clinical signs during the IKC outbreak in 2013 were as severe as those reported in
other IKC outbreaks in wild Caprinae (27, 33) and in naive domestic sheep ﬂocks (25,
34). According to the progression of clinical signs and the molecular and serological
results, the IKC outbreak probably started before July 2013, and clinical resolution (no
severe IKC stage II or III) was observed by November 2013. However, both seroconver-
sion and M. conjunctivae detection in the last 2013 handling indicate that there was still
transmission of M. conjunctivae among ibexes almost 5 months after identiﬁcation of
the ﬁrst IKC cases.
Asymptomatic postepizootic M. conjunctivae persistence. The sequences ob-
tained from asymptomatic infections in 2014 were very similar to the sequences from
the IKC epizootic in 2013, indicating that the same M. conjunctivae lineage persisted
after the initial disease outbreak. Whether M. conjunctivae persisted throughout the
whole study period in the captive population or was reintroduced is not known, but
persistence in host populations through singular mechanisms of host immune evasion
is a common feature of mycoplasma infections (2, 35, 36). It is unlikely that a rare event,
such as the introduction of similar M. conjunctivae strains from outside the double-
fence enclosure, occurred over 2 consecutive years. On the other hand, the known
TABLE 2 Linear mixed-model selection performed to assess the effect of ELISA results
(proxy for IgG response) on CT values obtained by a M. conjunctivae-speciﬁc qPCR (proxy
for M. conjunctivae loads) in eye swabs of Iberian ibexesa
Biological model K AICc i wi Marginal R2 Conditional R2
Age 5 38.47 0.00 0.80 0.61856109 0.68359573
Age  yr 6 43.26 4.79 0.07 0.61088941 0.67602488
Age  ELISA 6 48.54 10.07 0.01 0.61074212 0.70032295
Yr 4 49.86 11.39 0.00 0.16534722 0.29751655
Mo 3 50.08 11.61 0.00 0.00000000 0.00652695
ELISA 4 57.87 19.40 0.00 0.03221345 0.03221350
ELISA  yr 5 58.69 20.22 0.00 0.15863676 0.28898391
Age  ELISA 8 67.30 28.83 0.00 0.58927052 0.60548979
aNested models for the random terms were ﬁtted with the individual ibex and the year (corresponding to
two epidemiological scenarios) as random effects. K, number of parameters; AICc, Akaike information
criterion corrected for small sample sizes; Δi, difference of AICc with respect to the best model; wi, Akaike
weight; marginal R2, observed variability in the response variable explained by the ﬁxed factors; conditional
R2, observed variability in the response variable explained by both the ﬁxed and random factors. The model
with substantial support is in bold.
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clinical outcome of the introduction of M. conjunctivae in a host population does not
correspond with the epidemiological scenario found in 2014 (25, 37). The persistence
of M. conjunctivae has also been recently suggested in free-ranging wild host popula-
tions (20).
Within-host persistence of M. conjunctivae after clinical recovery has been reported
from 3 to 6 months in sheep (15) and at least up to 2 months in Alpine ibex (Capra ibex)
(14). In the Iberian ibex, the maximum period of infection demonstrated in this study
was 7 weeks in 2013. Given that mycoplasma virulence and clinical signs are positively
related with transmission in ocular diseases (38), the high M. conjunctivae prevalence
detected in 2014 was presumably achieved by chronic persistence in the eyes (15).
Altogether, this suggests that M. conjunctivae probably became endemic in the Iberian
ibex population with apparently low health implications, as typically reported in
domestic sheep ﬂocks (16, 39).
Age and sex effect. The higher prevalence of M. conjunctivae in younger Iberian
ibexes during the IKC outbreak concurs with previous studies that reported higher M.
conjunctivae prevalences in yearling ibexes (12) and lambs (39). A speciﬁc role of lambs
for M. conjunctivae persistence in sheep ﬂocks has also been suggested based on this
higher prevalence and milder clinical signs (15, 40). However, there were no age class
differences in M. conjunctivae in the ibexes in 2014, suggesting that this potential age
factor may be dynamic and dependent on the established interaction between the
hosts and the circulating mycoplasma strains. In contrast with previous reports of IKC
epizootics in sheep and chamois (27, 40–42), more severe clinical signs and higher
mycoplasma DNA loads were exhibited by kids than adults in this study. It suggests that
in this case, ocular tissue damage was apparently directly caused by M. conjunctivae
and was probably less inﬂuenced by the adverse effects of exacerbated immune
responses (2, 20, 43). Captive conditions may have had an inﬂuence on these results
and on the lack of female-biased IKC described in disease outbreaks (26, 33).
Immune IgG response. Strong immune reactions against M. conjunctivae, as de-
scribed in natural IKC outbreaks, were observed in the ibexes (Fig. 4). However, M.
conjunctivae detection was not always consistent with a subsequent increase in IgG in
sera, as was previously reported (37, 44), and this suggests that a systemic involvement
of the immune system is not always triggered by the ocular infection. Moreover, mixed
models indicated that systemic antibodies had a limited role in recovery from infection,
which is not rare in mycoplasmas (45–48). Acquired immunity may be therefore based
on the local production of IgG, other immunoglobulins, and/or local immune mecha-
nisms that occur in mucosal and local infections (45, 49).
Mycoplasmas typically cause chronic and persistent infections, and systemic IgG
titers can be maintained stably in sera for long time periods through continuous
stimulation of the immune system (47). Systemic IgG levels in the Ibexes were, however,
short-lived, which agrees with some previous reports of single natural infections (50,
51). These results further suggest that systemic IgG does not play an important role for
acquired immunity against M. conjunctivae.
Since the immune responses of the ibexes were assessed by an antigen-based
diagnostic technique, changes in the antigenic proﬁle of M. conjunctivae during the
infection can explain part of the individual variability observed (35). Although the
indirect ELISA may not be a good diagnostic tool for M. conjunctivae infection in case
studies, it has been demonstrated to be effective for M. conjunctivae surveillance in
Iberian ibex populations. Further research is needed to elucidate the immune mecha-
nisms developed by ruminant hosts to face and overcome M. conjunctivae infection.
Host-pathogen interactions. Two different epidemiological scenarios were found
in the ibex population, suggesting different Mycoplasma-host interactions if we con-
sider the prevalence, the M. conjunctivae DNA abundance, and the clinical outcome of
the infection. The clearance of M. conjunctivae from the eyes in most of the Iberian
ibexes that suffered from severe IKC (2013 outbreak) indicated that the infection
triggered a host reaction directed toward the elimination of ocular infections. The
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subsequent higher prevalence of asymptomatic infections in 2014, however, suggests
a longer low-DNA M. conjunctivae (proxy for bacterial load) persistence in the eyes,
owing to changes in the host-M. conjunctivae interaction. Similar to these results, low
mycoplasma loads have been associated with minimal direct damage to the epithelium
and with persistent infections (52), and a correlation between disease severity and M.
conjunctivae loads has also been reported in free-ranging chamois and Alpine ibexes
independently of the infecting strain (11, 12). The transition between the two scenarios
observed is consistent with transmission/recovery trade-offs of pathogen virulence, in
which gained virulence favors persistence by reducing the upregulation of the immune
response of the host with a lower replication rate (loads) and tissue damage (53, 54).
Evidence of one past ocular inﬂammatory process in 2014 (IKC stage V) in at least
one Iberian ibex, however, suggests that the infection may still be pathogenic if
inﬂuenced by other factors (12, 16, 55).
Conclusions. This study allows a better understanding of the transition between
two different M. conjunctivae epidemiological scenarios described and highlights the
ability of M. conjunctivae to establish diverse interactions with its hosts. The outcome
of the M. conjunctivae infection can be varied and more dependent on a speciﬁc
host-mycoplasma interaction rather than intrinsic host species traits (i.e., susceptibility).
Protective immune reactions against M. conjunctivae are not based on a systemic IgG
response, which is probably not important to prevent repeated infections in the Iberian
ibex.
Infectious diseases have been identiﬁed as potential threats for wild Iberian ibex
populations (24). The surveillance of M. conjunctivae infection and the potential impact
in free-ranging Iberian ibex populations may therefore be considered in future studies
on the management of this species. The potential role of the Iberian ibex as a reservoir
host for other susceptible species should be also considered in animal health policies.
MATERIALS AND METHODS
Study area and sampling procedure. This study was performed in a stock reservoir of 60 captive
Iberian ibexes located in Dílar (37°03=N, 03°33=W [WGS84 coordinate system]), within the Sierra Nevada
Natural Space (SNNS) (southern Spain). The double-fence enclosure was built in 1993 to preserve the
genetic diversity of the Iberian ibex population of SNNS from the massive die-offs that occurred because
of sarcoptic mange (Sarcoptes scabiei) in the late 1980s (56). This enclosure includes 30 ha of Mediter-
ranean forest composed of pine woods (Pinus spp.) and Mediterranean shrubs. Herd size can vary in
about 15% over a year, and the herd is handled yearly for health surveillance. The captive population was
historically free of ocular disease until summer/autumn 2013, when an IKC outbreak occurred.
A longitudinal sampling was performed on the captive ibex population, which was sampled yearly
between 2010 and 2014, except for 2012, when no samples were collected, and 2013, when the outbreak
took place and up to three handlings were carried out (Table 1). For each handling, ocular swabs were
taken of each eye between the third eyelid and the palpebral conjunctiva with sterile cotton swabs.
Blood samples were also collected from jugular veins from 2013 onwards. From October 2013 to April
2014, ocular swabs and blood samples from 17 free-ranging ibexes captured in the SNNS were also
collected (Table 1). Captures were performed for other purposes by means of tele-anesthesia (combi-
nation of 3 mg/kg of body weight xylazine and 3 mg/kg ketamine) (57).
Blood samples were placed in sterile tubes, allowed to clot at room temperature, and centrifuged at
1,500 g to obtain the sera. Ocular swabs and the resulting serum samples were stored frozen at20°C
within 24 h from sample collection. Sex determination was made by visual inspection of genitalia, and
age was determined by counting the annual horn segments (58). The ibexes were classiﬁed into ﬁve
different age categories according to social segregation and aging process: kids, less than 6 months;
yearlings, from 6 months to 2 years; young, from 2 to 3 years; prime age, from 3 to 7 years; and
senescence from 8 years onwards (11, 24, 59).
The handling procedures of the ibexes were designed to minimize stress and health risks for subjects
in accordance with the current guidelines for ethical use of animals in research (60) and the European
(2010/63/EU) and Spanish (R.D. 53/2013) legislations. This study complied with all Andalusian, Spanish,
and European legal requirements and guidelines regarding animal welfare, was approved by the Ethics
on Animal Welfare Committee of the Universidad de Jaén, and was authorized by the Dirección General
de Producción Agrícola y Ganadera of the Consejería de Agricultura, Pesca y Medio Ambiente of the
Junta de Andalucía.
Clinical signs. Ocular clinical signs were macroscopically classiﬁed into seven categories based on
severity and resolution course of the ocular disease (61) (see Fig. 1): 0, asymptomatic (no apparent clinical
signs); I, mild signs (hyperemia of the conjunctiva and moderate ocular discharge without evident
corneal damage or inﬂammation); II, moderate signs (ocular discharge, moderate corneal opacity, and
neovascularization of peripheral cornea); III, severe signs (ocular discharge, widespread and severe
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corneal opacity, and neovascularization of peripheral and central cornea); IV, very severe signs (clinical
signs of stage III might be present along with staphyloma and/or corneal perforation); V, evidence of
clinical resolution (slight central opacity of the cornea; concentric pigmentation of the cornea and central
neovascularization might be still present); VI, clinical resolution without current inﬂammatory features
(invading pigmentation from the limbus to the vertex of the cornea).
Mycoplasma conjunctivae qPCR detection and sequencing. For M. conjunctivae detection, eye
swabs were placed with 0.5 ml of lysis buffer (100 mM Tris-HCl [pH 8.5], 0.05% Tween 20, 0.24 mg/ml
proteinase K) into sterile tubes and were mixed with a vortex. Lysis of the cells was performed at 60°C
for 60 min, followed by inactivation of the proteinase K at 97°C for 15 min.
Lysates were directly used as the test sample in a M. conjunctivae-speciﬁc qPCR (62). Each
reaction mixture consisted of 2.5 l of the sample, 900 nM LPPS-TM-L (5=-CAGCTGGTGTAGCACTTT
TTGC-3=) and LPPS-TM-R (5=-TTAACACCTATGCTCTCGTCTTTGA-3=) primers, 300 nM LPPS-TM-FT probe
(5=-TGCTTCGACTACCAAATATGATGGTGATCCTCT-3=; 6-carboxyﬂuorescein [6-FAM] 5= reporter dye
and 6-carboxytetramethylrhodamine [TAMRA] quencher 3=), 12.5 l of 2 TaqMan universal PCR
master mix (Applied Biosystems, Warrington, UK), an exogenous internal positive control (IPC; Applied
Biosystems), and water up to 25 l of volume. The cycle threshold was set at 0.05, and the PCR cycle
when the sample ﬂuorescence crossed the threshold was recorded as the CT value, which inversely
corresponds to the initial amount of target DNA in the test sample. All samples were analyzed in
duplicate, including positive and negative controls, and positive-sample reactions were repeated if
standard deviation between the replicates was more than one CT.
For molecular epidemiological studies, a nested PCR that targets the 3= end of the gene coding for
the serine-rich part of the membrane protein LppS of M. conjunctivae was performed on randomly
selected samples with low CT values by the qPCR. The reactions were performed according to Belloy et
al. (17), with minor modiﬁcations of the primers, using the Serstart3 (5=-TTTAGTAGACTCCACTTCACC-3=)
and LppTA2 (5=-TTTGATCTCTCCACCTTCAGC-3=) primers for the ﬁrst PCR and Serstart2 (5=-CACTATACTT
AACAGATAGTCC-3=) and LppTA (5=-GGCACTAATAGTGCGTAATTC-3=) primers in a nested reaction if the
ﬁrst ampliﬁcation was not enough.
For DNA sequence analyses, all products from the nested PCR were puriﬁed with the High Pure PCR
product puriﬁcation kit (Roche Diagnostics, Rotkreuz, Switzerland). The sequencing of the amplicons was
performed using the Ser_start2, Ser_start0 (5=-ATACTCAAAGTGGAAATAATGGAA-3=), and Ser_end0
(5=-GCAACAACAATAGTAAGAGCAG-3=) primers using the BigDye Terminator cycle sequencing kit (Ap-
plied Biosystems, Foster City, CA, USA).
The resulting sequences were trimmed to obtain the variable part of the lppS gene corresponding to
nucleotide positions 3935 to 5035 of lppS of the M. conjunctivae type strain HRC/581 (accession no.
AJ318939). Alignment and editing of the sequence data were performed with the BioEdit software. A
cluster analysis tree of the sequences was inferred using the unweighted pair group method using
average linkages (UPGMA) with 1,000 bootstrap replications, performed with the MEGA 7 software (63).
DNA sequence data from the type strain HRC/581 (GenBank accession no. LT174654) and from six strains
more from different hosts and geographical placements (2880 s, accession no. LT174667; 38 s, accession
LT174670; My 66 95 s, accession no. LT174668; My 7/96 g, accession no. LT174669; 2778 c, accession no.
LT174666; and 2784 c, accession no. LT174671) were included in the tree for comparison.
ELISA for M. conjunctivae antibodies. The humoral immune response against the M. conjunctivae
infection was assessed in sera with an indirect ELISA based on the Tween 20 membrane proteins extract
of the M. conjunctivae strain HRC/581T (64). This ELISA showed good sensitivity and speciﬁcity for M.
conjunctivae antibodies in sheep and has also been validated for alpine chamois (Rupicapra rupicapra)
(10, 15). Cross-board titrations were performed to determine the serum sample dilution, the concentra-
tion of Tween 20 extracts, and the conjugated antibodies to obtain an optimal signal/noise ratio. All the
samples were analyzed in duplicate, and all serum samples from the same ibex were included in the
same ELISA plate to have the same analytical conditions for each individual. Serum from a captive-born
ibex negative for the M. conjunctivae-speciﬁc qPCR in eye swabs that never had ocular disease was used
as the negative reference standard. On the other hand, serum from an ibex that showed severe IKC
during the outbreak and with M. conjunctivae infection conﬁrmed by qPCR was used as the positive
reference standard.
For ELISA development, Nunc A/S MaxiSorp microtiter plates (Nunc, Roskilde, Denmark) were coated
with the Tween 20 extracts at an optical concentration of 5 g/ml, according to standard methods (65).
Brieﬂy, serum samples were applied to the plates diluted 1:50 with a 5 ELISA diluent solution
(eBioscience, San Diego, CA, USA) and incubated for 90 min at room temperature. Then, the wells were
washed, and a monoclonal anti-sheep/goat IgG antibody conjugated to horseradish peroxidase (Sigma,
St. Louis, MO, USA) diluted 1:15,000 was added and incubated for 90 min at room temperature.
Subsequently, the wells were washed, and the chromogen solution 3,3=,5,5=-tetramethylbenzidine
(Sigma) was added and incubated for 15 min according to the producers’ instructions, when 0.16 M
sulfuric acid was applied to stop the reaction. The values of the samples were calculated as the mean
optical density of the duplicates measured at 405 nm (OD450) and were expressed as the percentage of
the positive reference standard, with the negative reference standard value as zero, according to
accepted methods (65).
The optimal cutoff point was obtained with the Youden index, which is the point at which maximum
sensitivity and speciﬁcity are achieved based on values of both diseased and healthy ibexes (66). Serum
samples from Iberian ibexes from two populations in Catalonia (Northeast Spain), where ocular disease
has not been described, were used as negative controls for the cutoff determination (n  71). On the
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other hand, serum samples from ibexes from the reported outbreak that exhibited ocular disease and
were positive with the qPCR were used as positive controls for the cutoff determination (n  33).
Statistical analyses. Data were analyzed separately for 2013 (epidemic IKC) and 2014 (nonepidemic
IKC). Mycoplasma conjunctivae infection was treated as a categorical variable, with two levels (positive
and negative), in which ibexes were considered positive if the qPCR result was positive in any of the three
samplings from 2013. Differences in M. conjunctivae prevalence related to age class and sex were
assessed with Fisher’s exact test.
To assess the importance of the IgG humoral response in the M. conjunctivae clearance, we ﬁt a set
of linear mixed-effects models (LMM) in which M. conjunctivae abundance in the eye (CT values of the
qPCR) was explained by the ﬁxed effects of IgG concentration (relative ELISA OD450), age class, and their
two-way interactions. Since at least two blood samplings (one each year) were taken from each ibex, the
ibex was considered a random term in the LMM, using a repeated measure-ﬁxed block design. Then, the
best random structure was selected according to Zuur et al. (67). For the purpose of this analysis and
in order to increase the sample size per category, the young, prime age, and senescence categories
were merged. Because of the short-term persistence of the IgG antibodies, only ibexes that were
positive with the qPCR were considered. The ELISA results were square root transformed to reduce
residual variability and the effects of outliers (68). A theoretic information approach based on
Akaike’s information criterion corrected for small sample sizes (AICc) was then used to select the best
model (69). Brieﬂy, competing models were ranked according to the difference between their Akaike
scores and the score of the model with the lowest AICc. The models that substantially explain the
observed variability have Akaike differences (Δi) of 2 units in comparison with the model with the
lowest AICc. Then, the Akaike weight (wi) was calculated to know the relative probability that a given
model is the best of those being compared. For the best models, the lack of residual patterns was
checked, and to obtain a general measure of goodness of ﬁt, the marginal (variance explained by the
ﬁxed terms) and conditional (by the ﬁxed and random terms) variances were also calculated,
according to the protocol reported by Nakagawa and Schielzeth (70).
All the statistical analyses were performed with the R software (71), setting  at 0.05 when
appropriate. The linear mixed models were ﬁtted with the R package “lme4” (72). The R package
“OpticalCutpoints” was used to determine the cutoff point of the indirect ELISA and the derived
estimates of the sensitivity and speciﬁcity with a 95% conﬁdence interval (CI) (73).
Accession number(s). The partial lppS gene sequences from the ibexes were deposited in GenBank
under the following accession numbers (OI, left eye; OD, right eye): LT629278 (C_507 OI), LT629279
(C_507 OD), LT629280 (C_686 OI), LT629281 (C_686 OD), LT629282 (C_506 OD), LT629283 (C_508 OD),
LT629284 (695 OI), LT629285 (C_695 OD), LT629286 (C_800 OI), LT629287 (C_2298 OI), LT629288 (C_5125
OI), LT629289 (C_5125 OD), LT629290 (C_801 OI), LT629291 (C_801 OD), LT629292 (575N OI), LT629293
(C_501 OD), LT629294 (C_801 OI), and LT629295 (ALP321 OI).
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